Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25)

• Published in: Clinical immunology and immunopathology Vol. 59; no. 1; p. 16
• Main Authors: Zola, H, Koh, L Y, Mantzioris, B X, Rhodes, D
• Format: Journal Article
• Language: English
• Published: United States 01-04-1991
• Subjects: Adult; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte - biosynthesis; Antigens, Differentiation, T-Lymphocyte - biosynthesis; CD4 Antigens - biosynthesis; CD8 Antigens; Fluorescent Antibody Technique; HIV Infections - immunology; Humans; Lymphocytes - metabolism; Male; Middle Aged; Receptors, Interleukin-2 - biosynthesis
• ISSN: 0090-1229
• DOI: 10.1016/0090-1229(91)90078-O

Using a high-sensitivity immunofluorescence procedure, a proportion of blood lymphocytes can be shown to express the p55 chain of the IL-2 receptor (CD25, TAC) without in vitro stimulation. In this study, we measured the proportion of peripheral blood lymphocytes expressing CD25 in patients with a diagnosis of HIV infection and compared the results with cells from controls. The mean value for HIV-positive samples was 15%, while controls gave a mean value of 31%. The difference between the groups was highly significant (P less than 0.001, Mann-Whitney U test). When expression of CD25 was examined separately in CD4-positive and CD8-positive T cells and in B cells, there was a wider spread of values in the HIV group compared with controls, but no systematic difference. In the patient group studied (110 samples from 53 patients) there was a weak correlation between CD25 and CD4 expression (correlation coefficient r = 0.21, P less than 0.02), but there were patients with low CD25 and high CD4 as well as patients with high CD25 and low CD4, suggesting that CD25 can vary independently of changes in CD4 lymphocytes. Although the majority of very low values of CD25 (less than 10%) were found in patients with stage IV disease, such low values were also common in Stage II disease.